Charles M. Perou

发表

Adjustment of systematic microarray data biases

Joel S. Parker, Dong Xiang, J. S. Marron, 2004, Bioinform..

ReQON: a Bioconductor package for recalibrating quality scores from next-generation sequencing data

Joel S. Parker, J. S. Marron, Matthew D. Wilkerson, 2012, BMC Bioinformatics.

Deep Multi-View Learning via Task-Optimal CCA pdf

J. S. Marron, Marc Niethammer, Roland Kwitt, 2019, ArXiv.

Topological Descriptors of Histology Images

J. S. Marron, Marc Niethammer, Charles M. Perou, 2014, MLMI.

Receiver operating characteristic curves and confidence bands for support vector machines

Michael R. Kosorok, Eric B. Laber, Daniel J. Luckett, 2018, Biometrics.

Merging two gene-expression studies via cross-platform normalization

Andrew B. Nobel, Cheng Fan, Charles M. Perou, 2008, Bioinform..

Assembly-based inference of B-cell receptor repertoires from short read RNA sequencing data with V’DJer

Joel S. Parker, Benjamin Vincent, Charles M. Perou, 2016, Bioinform..

An Integrative Boosting Approach for Predicting Survival Time With Multiple Genomics Platforms

Joel S. Parker, Andrew B. Nobel, Donglin Zeng, 2018, bioRxiv.

Multiclass Distance-Weighted Discrimination

Michael J. Todd, James Stephen Marron, Ying Du, 2013 .

Multiple Instance Learning for Heterogeneous Images: Training a CNN for Histopathology

J. S. Marron, Marc Niethammer, Melissa A. Troester, 2018, MICCAI.

Clustering microarray-derived gene lists through implicit literature relationships

Jonathan D. Wren, Charles M. Perou, Harold R. Garner, 2007, Bioinform..

Joint and individual analysis of breast cancer histologic images and genomic covariates

Marc Niethammer, Jan Hannig, Charles M. Perou, 2019 .

Visualization of Cross‐Platform Microarray Normalization

Joel S. Parker, James Stephen Marron, Charles M. Perou, 2009 .

Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: comparison of gene expression profiling approaches

Charles M. Perou, Carlos Martinez-Perez, Richard Clark, 2020, BMC Bioinformatics.

Hierarchical task-driven feature learning for tumor histology

J. S. Marron, Marc Niethammer, Charles M. Perou, 2015, 2015 IEEE 12th International Symposium on Biomedical Imaging (ISBI).

SCDC: bulk gene expression deconvolution by multiple single-cell RNA sequencing references

Fei Zou, Yuchao Jiang, Charles M. Perou, 2019, bioRxiv.

Antagonism of EGFR and HER3 Enhances the Response to Inhibitors of the PI3K-Akt Pathway in Triple-Negative Breast Cancer

Borivoj Vojnovic, Dejan Juric, Charles M. Perou, 2014, Science Signaling.

Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy

Charles M. Perou, Katherine A. Hoadley, Laia Paré, 2015, BMC Medicine.

Differences in race, molecular and tumor characteristics among women diagnosed with invasive ductal and lobular breast carcinomas

Michael I. Love, Melissa A. Troester, Charles M. Perou, 2019, Cancer Causes & Control.

Prognostic B-cell Signatures Using mRNA-Seq in Patients with Subtype-Specific Breast and Ovarian Cancer

Charles M. Perou, Katherine A. Hoadley, Michael D. Iglesia, 2014, Clinical Cancer Research.

Integrated study of copy number states and genotype calls using high-density SNP arrays

Fred A. Wright, Tianwei Yu, Wei Sun, 2009, Nucleic acids research.

Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse

Charles M. Perou, J. Chuck Harrell, Joel S. Parker, 2011, Breast Cancer Research and Treatment.

Molecular features of the basal-like breast cancer subtype based on BRCA1 mutation status

Charles M. Perou, Katherine A. Hoadley, Judith Balmaña, 2014, Breast Cancer Research and Treatment.

Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA , IDH 1 , EGFR , and NF 1 Citation Verhaak

Yuan Qi, Jill P. Mesirov, Li Ding, 2010 .

Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast Cancer

Jian Jin, Charles M. Perou, Katherine A. Hoadley, 2012, Cell.

A framework for transcriptome-wide association studies in breast cancer in diverse study populations

Arjun Bhattacharya, Michael I. Love, Melissa A. Troester, 2019, Genome Biology.

Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

Marc E. Lenburg, Donald A. Berry, Olufunmilayo I. Olopade, 2011, Breast Cancer Research and Treatment.

Frequency of breast cancer subtypes among African American women in the AMBER consortium

Zhiyuan Hu, Yan Li, Melissa A. Troester, 2018, Breast Cancer Research.

Ductal Carcinoma In situ and the Emergence of Diversity during Breast Cancer Evolution

Charles M. Perou, Iris D. Nagtegaal, D. Craig Allred, 2008, Clinical Cancer Research.

Responsiveness of Intrinsic Subtypes to Adjuvant Anthracycline Substitution in the NCIC.CTG MA.5 Randomized Trial

Mark T. W. Ebbert, Charles M. Perou, Samuel Leung, 2012, Clinical Cancer Research.

Race-associated biological differences among Luminal A breast tumors

Melissa A. Troester, Charles M. Perou, C. Perou, 2015, Breast Cancer Research and Treatment.

Triple-Negative Breast Cancer: Risk Factors to Potential Targets

Charles M. Perou, George W. Sledge, Andrea Richardson, 2008, Clinical Cancer Research.

Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas

Peter W. Laird, Olufunmilayo I. Olopade, Charles M. Perou, 2017, JAMA oncology.

Abstract 1598: LncRNA AK001796 as a therapeutic target in aggressive breast cancers

Jeffrey M. Rosen, Charles M. Perou, John S. Mattick, 2016 .

HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis.

Charles M. Perou, Carla Rognoni, Pier Franco Conte, 2020, Cancer treatment reviews.

Differential Pathogenesis of Lung Adenocarcinoma Subtypes Involving Sequence Mutations, Copy Number, Chromosomal Instability, and Methylation

Matthew D. Wilkerson, Charles M. Perou, Vonn Walter, 2012, PloS one.

SWISS MADE: Standardized WithIn Class Sum of Squares to Evaluate Methodologies and Dataset Elements

J. S. Marron, Matthew D. Wilkerson, Charles M. Perou, 2010, PloS one.

A Comparison of Gene Expression Signatures from Breast Tumors and Breast Tissue Derived Cell Lines

Charles M. Perou, C. Perou, D. Ross, 2002, Disease markers.

Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

Clement Adebamowo, Ritika Kundra, Steven J. M. Jones, 2018, Cell reports.

Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

Charles M. Perou, Samuel Leung, Philip S. Bernard, 2009, Journal of the National Cancer Institute.

Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy

Roman Rouzier, Charles M. Perou, W. Fraser Symmans, 2005, Clinical Cancer Research.

Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes

Charles M. Perou, Melissa Troester, J. Chuck Harrell, 2011, Breast Cancer Research and Treatment.

Multiple roles of cyclin-dependent kinase 4/6 inhibitors in cancer therapy.

Charles M. Perou, Kwok-Kin Wong, William C. Zamboni, 2012, Journal of the National Cancer Institute.

A Core MYC Gene Expression Signature Is Prominent in Basal-Like Breast Cancer but Only Partially Overlaps the Core Serum Response

Sarah A. Pendergrass, Charles M. Perou, Michael L. Whitfield, 2009, PloS one.

Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival

Olufunmilayo I. Olopade, Vessela N. Kristensen, Charles M. Perou, 2011, Breast Cancer Research and Treatment.

The molecular diversity of Luminal A breast tumors

Chris Sander, Charles M. Perou, Katherine A. Hoadley, 2013, Breast Cancer Research and Treatment.

Erratum: Diversity of gene expression in adenocarcinoma of the lung (Proceedings of the National Academy of Sciences of the United States of America (2001) 98 (13784-13789))

Russ B. Altman, David Botstein, Olga G. Troyanskaya, 2002 .

PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer

Donald A. Berry, Mark T. W. Ebbert, Charles M. Perou, 2013, Breast Cancer Research and Treatment.

Abstract 4875: Human HER2 and PI3K H1047R cooperate to promote mammary tumorigenesis in vivo

Charles M. Perou, Rebecca S. Cook, Carlos L. Arteaga, 2012 .

Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling

David Haussler, Olga G. Troyanskaya, Charles J. Vaske, 2011, Proceedings of the National Academy of Sciences.

Asparagine bioavailability governs metastasis in a model of breast cancer

Charles M. Perou, J. Chuck Harrell, George Poulogiannis, 2018, Nature.

ABRA: improved coding indel detection via assembly-based realignment

Matthew D. Wilkerson, Charles M. Perou, D. Neil Hayes, 2014, Bioinform..

Comprehensive molecular characterization of clear cell renal cell carcinoma

Charles M. Perou, 2013 .

Erratum: Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles (Cell Reports (2017) 18(11) (2780–2794) (S2211124717302140) (10.1016/j.celrep.2017.02.033))

Steven J. M. Jones, Chris Sander, Li Ding, 2017 .

Erratum: The somatic genomic landscape of glioblastoma (Cell (2013) 155 (462-477))

Chris Sander, David Haussler, Wei Zhang, 2014 .

Patterns of cell cycle checkpoint deregulation associated with intrinsic molecular subtypes of human breast cancer cells

Joseph G. Ibrahim, Matthew A Psioda, Charles M. Perou, 2017, npj Breast Cancer.

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

Jeffrey M. Rosen, Charles M. Perou, Susan G. Hilsenbeck, 2009, Proceedings of the National Academy of Sciences.

Deconstructing the molecular portraits of breast cancer

Charles M. Perou, C. Perou, A. Prat, 2010, Molecular oncology.

Practical implications of gene-expression-based assays for breast oncologists

Charles M. Perou, Matthew J. Ellis, C. Perou, 2012, Nature Reviews Clinical Oncology.

A framework for transcriptome-wide association studies in breast cancer in diverse study populations

Arjun Bhattacharya, Michael I. Love, Melissa A. Troester, 2020, Genome Biology.

An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in Cancer*

Li Ding, David L. Tabb, Daniel C. Liebler, 2015, Molecular & Cellular Proteomics.

Tumor classification using gene expression patterns from DNA microarrays

Charles M. Perou, D. Botstein, P. O. Brown, 2000 .

Potential Tumor Suppressor Role for the c-Myb Oncogene in Luminal Breast Cancer

Charles M. Perou, Katherine A. Hoadley, Joel S. Parker, 2010, PloS one.

BlackOPs: increasing confidence in variant detection through mappability filtering

J. S. Marron, Jinze Liu, Matthew D. Wilkerson, 2013, Nucleic acids research.

RERG Is a Novel ras-related, Estrogen-regulated and Growth-inhibitory Gene in Breast Cancer*

David Botstein, Charles M. Perou, Patrick O. Brown, 2001, The Journal of Biological Chemistry.